The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.
about
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death thresholdSecondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate.Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literature.SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis.Patients with chronic myeloid leukemia treated with imatinib who showed the appearance of clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells.Targeting developmental pathways in children with cancer: what price success?European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phaseTherapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors.Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors.Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia.Prognostic Significance of Treatment Response in CML in View of Current Recommendations for Treatment and Monitoring.Do we need more drugs for chronic myeloid leukemia?Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress.Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia.Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib.Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an update.Clonal chromosomal abnormalities in Philadelphia-negative cells in chronic myeloid leukemia patients treated with nilotinib used in first-line therapy.Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.Clinical course of patients with incidental finding of 20q- in the bone marrow without a morphologic evidence of myeloid neoplasm.Molecular diagnostics in chronic myeloid leukemia.Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant.Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemia.Trisomy 8 in Philadelphia chromosome negative cell preceding the evolution of a Philadelphia chromosome positive clone with the same additional change during imatinib treatment: revisiting the role of genetic instability in chronic myeloid leukemia.Clonal cytogenetic abnormalities after tyrosine kinase inhibitor therapy in Ph+ ALL resolution after decitabine therapy.Therapy of Newly Diagnosed and Chronic-Phase Chronic Myeloid Leukemia
P2860
Q27853066-A1745917-4474-4BBB-9496-C45927414CE9Q28704493-87FF5D99-7CFA-44DD-9358-144235757DE3Q33861815-477102FA-8ED5-4258-9381-EB6118B66AC7Q33878774-07209D34-5326-4DEA-B6E8-07D012BB9A08Q34081581-66315AAB-C4CA-4A5A-993B-9B1338C2902BQ35668398-4A874D95-B6E7-4298-8071-A4D9C9093B29Q36905620-71622262-4CEC-4CA9-B396-BA9A2D928D25Q37026032-1EA85531-F02D-4C31-83A7-CE4255E4108DQ37163550-1228CE13-F9AE-49EC-8652-72FEC1CA420BQ37163834-A47FC380-C975-4FC9-ADFC-B4189C670375Q37271941-6B769C55-A117-4582-9C72-2247A654A13EQ37360559-1F532DFA-4DE1-4151-8134-914F2BE2B197Q37651599-9DBF21FA-4E89-4BB3-8AC5-C2F607BF65D6Q37896015-030FDF1A-A56F-48F8-9588-C9311BBF453BQ38095956-FA849DA0-6EB3-4EE1-9CA4-F68B903C8AA1Q38289033-DB2F1FA9-02F6-4E14-8157-9DA8C67D83DAQ38685696-DFF9125C-9F13-4724-AAE4-5B01628AEE93Q42126174-B18C7D34-A42A-4F38-AC2F-3FA176F7B3FDQ42650776-8F26C306-59A2-4A4D-8C20-F100A5427847Q42665076-130AD3A0-7A25-4CE3-BFD4-C8F35D859405Q43266877-94151287-CFDE-45E4-BAAF-63E6F44C57D6Q45895862-9A171800-5876-4F44-B577-F5C5C7034139Q45991055-245B3A9C-9403-448E-87C9-2D8436662E60Q48186139-D4261876-14F2-4952-B348-83EA6B80F64EQ49993294-4759C206-54B2-448D-8E5D-6BE5470C8205Q50884247-E5274DEE-48AE-42DF-A381-A659118F3312Q51072279-F55744C0-A86D-44EC-9145-1964AAED3243Q52882588-CBE99DD8-DEC9-4B38-9CE6-2E7EF6576451Q53178315-5E85E0B4-25B5-4051-83C4-45D6D0D427CBQ53469467-9736F28E-5EF4-46E8-83F4-A642D49543C3Q54317762-5F7C801A-BE6C-4446-855F-006568C16027Q54353234-ABB5E8DF-09B2-42D3-B7A1-05E1F8A36DCFQ54561399-40044254-8266-4846-BFE4-A1F37BCE993BQ58023832-D63FF242-B1D5-4CA2-B086-AB240C483B54
P2860
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The prognosis for patients wit ...... hia chromosome-negative cells.
@ast
The prognosis for patients wit ...... hia chromosome-negative cells.
@en
type
label
The prognosis for patients wit ...... hia chromosome-negative cells.
@ast
The prognosis for patients wit ...... hia chromosome-negative cells.
@en
prefLabel
The prognosis for patients wit ...... hia chromosome-negative cells.
@ast
The prognosis for patients wit ...... hia chromosome-negative cells.
@en
P2093
P50
P356
P1433
P1476
The prognosis for patients wit ...... hia chromosome-negative cells.
@en
P2093
Byung Park
Charlene So
Dietger Niederwieser
Douglas Smith
Insa Gathmann
John M Goldman
Michael W N Deininger
Richard Stone
Ron Paquette
Thomas Fischer
P304
P356
10.1002/CNCR.22936
P407
P50
P577
2007-10-01T00:00:00Z